• Dom. Dic 7th, 2025

NIH

  • Home
  • Il microbioma alleato contro il mieloma multiplo

Il microbioma alleato contro il mieloma multiplo

Un nuovo studio internazionale, guidato dal gruppo del dottor Matteo Bellone,responsabile dell’Unità, Immunologia cellulare dell’IRCCS Ospedale San Raffaele e dalla dottoressa Urvi A. Shah, ematologa – oncologa del Memorial Sloan…

Repeated head impacts cause early neuron loss and inflammation in young athletes

Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young- to middle-aged…

Quitting smoking is associated with recovery from other addictions

Adults who smoke cigarettes and are addicted to alcohol or other drugs were more likely to achieve sustained remission of their substance use disorder symptoms if they also quit smoking,…

NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases

Researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) agent powered by a large language model (LLM) that creates more accurate and informative descriptions of…

Budget request would stunt U.S. cancer research and risk future advances in cancer care #ASCO25

Today the administration released the details of its proposed FY 2026 budget request, including a nearly 40% reduction in funding for the National Institutes of Health (NIH) and the National…

NIH scientists pioneer promising treatment for intractable cancer pain

National Institute of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the plant-derived molecule resiniferatoxin (RTX) shows that it is a safe and…

Older adults respond well to immunotherapy despite age-related immune system differences

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins…

NIH researchers develop eye drops that slow vision loss in animals

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss…

Aviaria. NHI, singola dose di anticorpo neutralizzante bnAb protegge i macachi dall’ influenza H5N1. Studio su Science

Una singola dose di un a,nticorpo neutralizzante (Broadly neutralising antibody bnAb), somministrato prima dell’esposizione al virus protegge i macachi dall’influenza aviaria grave H5N1. Lo riferiscono gli scienziati del National Institutes…

Subclinical Disease in Monkeys Exposed to H5N1 by Mouth and Stomach

A new study published in Nature found that highly pathogenic H5N1 avian influenza virus (HPAI H5N1) administered directly into the mouth and stomach of research monkeys caused self-limiting infection with…